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In the previous three communications on the mechanism of action of sulf- 
anilamide, Sevag and Shelburne (1) reported that this drug primarily blocked 
bacterial cell respiration in the absence as well as in  the presence of active 
growth.  The inhibition of aerobic and anaerobic respiration resulted in the 
proportional inhibition of growth under the conditions used.  p-Aminobenzoic 
acid  often  reversed  partly  or  completely  the  inhibition  of  respiration  by 
sulfanilamide. 
On the basis of the above findings and those of others reviewed previously (1), 
a theory correlating the drug action with the similarity of chemical structures 
of  the  drugs  and  the  coenzymes  was  formulated.  It  was  stated that 
the chemotheraPeutic substances which have structural similarity to the whole, 
or part of the coenzyme molecules may combine specifically with the protein 
carrier of the respiratory enzymes--the result being the displacement of the 
coenzymes by the drug and the formation of an inactive "enzyme-analogue" 
or  the  formation  of  a  hypothetical  "drug-protein-coenzyme"  complex. 
These being incapable of oxidizing glucose, bacterial respiration and growth are 
inhibited.  In advancing this theory reservations were  made  to  account  for 
the activity of such drugs as do not possess structural similarity with the known 
coenzymes.  In such cases mutual affinity between the drug and the specific 
enzyme proteins was considered as a possible determining factor. 
In accordance with the  above  theory sulfapyridine, for example,  with its 
pyridine ring was mentioned as a potential competitor of cozymase I  and II, 
and sulfathiazole (likewise sulfadiazine) of cocarboxylase.  These coenzymes 
are present in the respiratory systems of most living cells.  They, therefore, 
offer the first point of attack in determining which link in the chain of reactions 
associated with the metabolism of glucose is affected most by a given sulfon- 
amide drug. 
* Article IV in a series on the mechanism of sulfonamide action.  The present study 
was conducted under grants from the Josiah Macy, Jr., Foundation and Merck and 
Company. 
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Bacterial and yeast carboxylase systems were chosen for this study as one of 
the means to test and corroborate the implications of the above theory.  The 
decarboxylation of pyruvic acid by carboxylase is of almost universal occurrence 
in living cells.  This reaction, carried out under anaerobic conditions, is prin- 
cipally a one-step reaction, and is relatively free from the interference of side or 
parallel reactions.  The effect of the drugs will be, therefore, directly on the 
carboxylase system.  To obtain clearer insight into the relative importance of 
various rings and radicals in the molecules of the drugs in inhibiting the car- 
boxylase system, the  widely used  sulfonamide  drugs,  their  homologues,  and 
their simple components were studied comparatively. 
The Enzyme  Systems Studied 
DETERMINATION  OF THE CARBOXYLASE  ACTIVITY OF BACrEI~IA AND YEASTS.-- 
Pneumococcus  Type  I, Streptococcus pyogenes  (C203M),  Staphylococcus aureus, 
Escherichia  coli,  and  brewer's  and  baker's  yeast  were  studied  to  determine the  optimal 
conditions  of their  carboxylase  activity. The experiments were carried  out anaero- 
bically  in  an atmosphere of  95 per cent nitrogen  and 5 per ccnt COs in  the presence 
of  sodium pyruvate solution. The CO2 evolved was measured manometricaUy with 
a Barcroft-Warburg set-up. All of the gas evolved was absorbable if KOH  was 
placed  in  the  inset  tube  of  the  vessel,  showing  the evolved gas  to  be C02. 
Pneumococcus  Type /.--Suspensions of Pneumococcus Type I, washed and un- 
washed, grown for 4 and 16 hours in serum broth,  in the presence  and absence of 
catalase  (to  eliminate  H2Os formed during growth), were tried  out in  three  separate 
experiments at pH 6.  In no case  did decarboxylation of pyruvate takc phce.  In 
parallel  experiments the  addition  of  I,  5,  I0,  and 1007  of  cocarboxylase  and  of  0.1  rag. 
of Mg did not produce any activity. Decarboxylation of pyruvic acid  by pneumo- 
cocci  (2) evidentally  takes  place  by a different  route  and will  be discussed  later. 
Streptococcus  pyogenes.--In  contrast,  similar  experiments  with  Streptococcus 
pyogenes (C203M)  grown for 16 hours in serum broth showed a residual carboxylase 
activity.  This activity was markedly augumented by the addition of cocarboxylase; 
33 c.mm. of COs were evolved in the absence of cocarboxylase while 124 c.mm. of 
CO2 were evolved when 100-}, of cocarboxylase were added.  In a second experiment 
a dense suspension of streptococci grown for 16 hours did not show any activity in the 
presence of 0.0517 ~r pyruvate, but the addition of 25"}, of cocarboxylase caused the 
evolution of 72  c.mm. of COs within  150 minutes.  An increase of  50 to  100-y of 
cocarboxylase did  not  improve this  activity.  The  activity being  too  small,  this 
organism was not further employed in the present study. 
Staphylococcus aureus.--Fresh  suspensions  of Staph. aureus grown for 4 to 16 hours 
exercised  uniform carboxylase activity, 4 mg. of cocci producing  400 c.mm. of COs 
in 120 minutes.  The dry weight of bacteria was estimated by micro-Kjeldahl nitrogen 
determ~nation.  The nitrogen values were multiplied by 7.2  as the protein  factor, 
assuming that the organism contains 14 per cent nitrogen. 
Carboxylase Activity before and after Drying Staphylococcus aureus from the Frozen 
State.--To have uniform carboxylase activity, it is necessary that the weight of the 
samples used in the daily experiments be identical.  Samples of Staph. aureus dried M.  G.  SEVAG, M.  SHELBU'RNE~ AND S.  MUDD  807 
from the frozen state proved satisfactory.  These organisms were twice washed with 
M/15  phosphate  buffer of pH  7.16  before  drying.  The  results  of a  comparative 
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FIG. 1.  Decarboxylation of pyruvic acid in Slaph. aureus.  Curves I, II, and III 
represent the activity of 14.4,  7.2, and 3.6 rag., respectively, of fresh Staph. aumus. 
Curves IA, IIA, and IIIA represent the activity of 14.4, 7.2, and 3.6 rag., respectively, 
of staphylococci dried from the frozen state. 
study of the fresh and the corresponding dried samples  of equal weights  (Fig.  1) 
show that on drying from the frozen state staphylococci experience practically no 
loss of carboxylase activity.  The addition of 1 to 10~, of cocarboxylase to the reac- 
tion system did not increase the activity of staphylococci. 
Optimal  Carboxylase Activity  of Dried  Stapkylococci.--Experiments  were  carried 808  RESPIRATION O~"  BACTERIA AND  YEAST 
out to determine the optimal activity as a function of pH and as a function of con- 
centration of substrate.  The results are given in Table I. 
Removal and Restoration  of Carboxylase Activity of Staphylococcus  aureus.--To test 
whether the  COs  evolved was  due to carboxylase the following experiments were 
carried  out.  Fresh  suspensions or  suspensions of  staphylococci  dried  from  the 
frozen state were treated according to the method of Lohmann and Schuster (3) to 
remove cocarboxylase.  Pure cocarboxylase  (Merck)  was  then added and the  de- 
TABLE I 
Carboxylase Activity of Dried Staphylococcus aureus As a Function of pH and of Substrate 
Concentration 
pH* 
7.28 
7.10 
6.54 
6.13 
COil2 hrs. 
c.mm. 
284 
279 
38O 
416 
Pyruvate 
0.017 M 
0.034 
0.052 
0.068 ,~ 
0.10  M 
CO,/2 hrs.$ 
c.mm. 
231 
332 
399 
492 
43O 
* The system contained 0.3 cc.  (26.4 nag.) pyruvate in a volume of 5.8 cc.  (0.0517 5). 
Weight of organisms per vessel 0.55 mg. of nitrogen, or 3.96 mg. of dry cocci.  Phosphate 
~/125.  Temperature 37.5  ° C. 
The experiments were carried out at pH 7.16 in consideration of the inhibition experi- 
ments with drugs which have greater solubility at this pH than at the pH of optimal activity. 
The reaction system was identical with that used in pH experiments except for varying quanti- 
fies of pyruvate. 
TABLE II 
Carboxylase Activity of Staphylococcus aureus before and after Treatment 
Treated with 
Untreated  ~/10 Na2HPO4 
c.mm.  C02  c.ram. CO~ 
508  245 
72l  466 
552 
Washed once with saline 
c.mm.C~ 
297 
Loss of activity 
lb~' cent 
52 
36 
46 
carboxylation of pyruvate was measured.  Treating the fresh suspensions of 4 hour 
staphylococci with ~r/10  Na2HPO4,  according to Lohmann and Schuster,  did not 
noticeably affect the carboxylase activity.  A sample which liberated 862 c.mm. of 
COs before treatment liberated 798 c.mm. of CO2 after treatment, (7 per cent reduc- 
tion of activity).  With the addition of 10~ of cocarboxylase to the treated sample, 
843 C.mm. of COs were evolved. 
On the other hand, if the staphylococci are dried from the frozen state and then 
washed with either ~/10 Na2HPO4 or 0.85 per cent NaC1 the activity is reduced about 
50 per cent (Table II).  The lost activity is nearly completely restored by the addition 
of cocarboxylase.  The activity of M/10 Na~HPO4  treated samples was restored to M.  O.  SEVAG~  M.  SHELBUI~NE~  AND  S.  MUDD  809 
76-85 per cent of the original on adding 1003" of cocarboxylase.  The activity of the 
saline washed sample was restored to 92 per cent of the original with 50 3' of cocar- 
boxylase, t 
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FIG. 2.  Decarboxylation of pyruvic acid in E. coll.  Curves I, II, and III represent 
the activity of 4.32,  1.73, and 0.86  rag., respectively, of fresh E. coll.  Curve IA repre- 
sents the activity of 4.32 rag. of E. coli dried from the frozen state. 
z The aerobic metabolism of pyruvic acid in Staph.  aureus has previously been in- 
vestigated (4, 5).  In connection with the present study the reader is referred to a 
paper by Krebs (6) on the anaerobic dismutation of pyruvic acid in Staph. aureus and 
Staph.  albus.  According to  Krebs,  following the  decarboxylation of one mole of 
pyruvate the resulting acetaldehyde with a  second mole of pyruvate metabolizes to 810  RESPIRATION OF  BACTERIA AND  YEAST 
Carboxylase Activity  of Escherichia coll.--In contrast to Staph.  aureus, the suspen- 
sions ofE. coli grown in glucose broth for 16 hours, twice washed with saline, and dried 
from the frozen state, were found completely  inactive.  When washed with ra/15 phos- 
phate buffer at pH 6, and then dried from the frozen state, a  sample of 2.2 nag. of 
E. coli liberated 234 c.mm. of CO2 in the presence of 0.0517  ~r pyruvate, but in later 
experiments the dried organisms had practically lost their activity.  In all the daily 
inhibition experiments, therefore, fresh suspensions of E. coli, twice washed with r~/15 
phosphate buffer of pH 7.1 and standardized with a photoelectric turbidometer, were 
used.  In an experiment the carboxylase activity of the fresh and dried suspensions 
of equal E. coli content was measured comparatively.  The results are given in Fig. 2. 
Yeast and Carboxylase prepared from Yeast.--The carboxylase activities of air-dried 
20 rag. samples of three different yeasts were measured at pH 6.23.  The CO2 evolved 
during a period of 90 minutes was as follows: brewer's fresh bottom yeast, 752 c.mm.; 
baker's yeast, 575 c.mm.; ale yeast, 531 c.mm. 
Using the method of Green, Herbert, and Submhmanyan (7) the carboxylase pre- 
pared from an old batch of air-dried brewer's yeast had little activity; a preparation 
from ale yeast was inactive.  A preparation from fresh air-dried brewer's yeast had a 
fair activity.  This solution after dialysis contained 0.256 mg. of N/cc.  No attempt 
was  made  to  purify this  preparation by  fractionation for inhibition experiments. 
0.6 co.  of  preparation  containing 0.15  rag. of N  evolved 90 c.mm. of CO2 at pit 6 
within 3 minutes.  At pH 7.16, 0.2 cc. of a sample (20 cc. sample dialyzed overnight 
against 1 liter of distilled  water) liberated 161 c.mm. of CO2 within 60 minutes in com- 
parison to a non-dialyzed sample which liberated 190 c.mm. of CO2.  Under identical 
conditions 5 nag. of air-dried fresh brewer's yeast liberated 234 c.mm. of CO2. 
Inhibition of Carboxylase by Sulfonamide Drugs and Their Derivatives 
The inhibitory effect of sulfonamide drugs and derivatives on the carboxylase 
activity of Staph. aureus, E. coli, baker's and brewer's yeast, and a carboxylase 
lactate and acetate, and this reaction is the preferential one.  Studying this reaction 
aerobically  he found that 0.1 ~ of pyruvate consumed 328 c.mm. 02, and anaerobically 
evolved 249  c.mm.  CO2 within a  95  minute period.  In our experiments 0.1  z~ of 
pyruvate consumed 52 c.mm. O2 and evolved 651 c.mm. total CO2 (free and bound as 
NaHC03),  within a  120 minute period.  Anaerobically 0.1  M pyruvate evolved 430 
c.mm. CO2.  In parallel experiments, the oxygen consumed by 0.1  ~  pymvate was 
52 c.mm. in contrast to 286 c.mm. O2 consumed by 0.05 ~r lactate.  These results show 
that the dismutation of pyruvate to lactate progresses at a very much slower rate than 
the decarboxylafion of pyruvate.  Within a 2 hour period, under the conditions of our 
experiments, not more than  10-20 per cent lactate could have been formed.  This 
small percentage of dismutation of pyruvie acid to lactic acid does not introduce an 
error into the interpretation of the results of the present study from the point of view 
of the action of sulfonamides on the activity of earboxylase. 
The discrepancy between our results and those of Krebs is of quantitative nature 
and not one of principle.  This is no doubt due to the difference of strains of Stapk. 
aureus used, conditions of culture, and of experiments.  Such differences in bacterial 
metabolic activity have been reported frequently (2, 5). TABLE  III 
Per Cent Inhibition of the Carboxylase Activity of Bacteria  and  Yeast by Sulfonamide Drugs 
Carboxylase systems 
~tapkylococcus aureus 
Mean inhibition 
!  Sulfanilamide 
No drug 
¢.121H1. 
C02 
evolved 
407*  8  9 
289*  3 
272* 
230* 
199" 
234* 
247* 
4025 
4085  1  2 
.....  52  5.0  2.0 
23,5* 
12525 
44S5 
Esd~rickia call  7735 
7675 
12455 
9675 
Mean inhibition .......... 
Baker's yeast  405 
160§ 
180 
331 
Brewer's yeast  335 
219 
219 
318 
biean inhibition ........  ] 
Carboxylase  from  131 
brewer's yeast  1581[ 
Mean inhibition ..........  ] 
17  52 
11  37 
5  33 
I ....  11.0 41 .C 
33  54 
20  58 
31  57 
I 
0  13  30 
7  7  27  53 
1  21  56 
30  25  44  0  15 
78  77 
12  0  0  2  29  66  8  26 
14  0  5  4  27  58  11  21 
3  0  17  39 
25  7  3  24  46  17  48  70 
7.2  8.0 
8  23 
2  12 
7  17 
1.0  2.5  3.0 23.5 53.2  21.0  46.0 73.2  6.3 21.0 
1 
2 
5.7  11•0  0.0  1.5  1.512.C 
38  25  42 
37  36  43 
24  31  23 
10  6  12  16  14 
12 
28.{3 56.~  24.2  30.6 
21  67  29  41 
15  57  21  36 
18.0 62£  25  38.5 
22  55 
6  34 
15  52 
15  49  15  59  85  9  14 
8  55  9  48  87  0  10 
0  0  3  7  44  0  8 
0  3  0  12  37  0  13 
0  7  17  10 
3.0  9.5 16.5 26.4 
46.~  12.0  53.5 86£  2.2 11.2 
71 
82 
63 
48  12 
51  44  I1  5  22 
54 
46 
42  3  12 
61.6  46.0  11 •{3 50.(  4.0 17.0 
45  ~t 
30  53 
372 ?8.5 
* Cryochem  dried  16 hour  cultures. 
** In a  comparative  study  the  inhibition  of  the  carboxylase  activity  of  Stapkylococcus 
aureus  at  the  end  of  120  minutes  was  50  per  cent  with  sulfathiazole,  15.8 per cent with 
2-aminothiazole; no effect was observed  with  2-aminopyrimidine  or  with  2-aminopyridine. 
The effect on E. colt was 46.3, 37.4, 4.1, and  10.1 per cent  inhibition  respectively.  The  in- 
hibitory  effect  on  yeast  carboxylase  activity  was 42, 6.4, 7.4, and 3  per  cent  respectively. 
The molarity of all drugs was 5.52  X  10  4. 
Fresh  16 hour cultures. 
§ Smaller values obtained with 5  mg of yeast; larger values obtained  with  10 mg of yeast. 
H Dialyzed• 
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preparation from brewer's yeast was studied.  In these experiments the op- 
timal conditions of carboxylase activity as described above were employed. 
Sparing solubility of some of these substances limited the maximum concen- 
tration to 1.38 X  10  -~ ~.  Where it was possible other drugs were compared at 
a concentration of 5.52  X  10  -3 ~ as weU, and sulfanilamide up to 27.6  X  10  -3 
~s.  The drugs were dissolved in a  saline-phosphate mixture of pH 7.16  (90 
cc. saline +  10 cc. M/15 phosphate buffer), heated to 56°C. if necessary. 
The reaction system contained, in a volume of 5.8 cc., the drug as indicated in 
Table III, the suspension of organisms, 0.1 rag. of Mg as magnesium chloride and 
26.4 mg. of pyruvic acid (0.0517 ~) neutralized to pH 7.1, and a final phosphate 
buffer concentration of ~/125.  Pyruvate in a volume of 0.5 cc. was introduced 
into the system from the side arm after temperature equilibration of the system. 
Although the optimal carboxylase activity takes place at pH 6.0, a system at 
pH 7.10 was used in consideration of the greater solubility of the drugs at this 
pH.  The duration of the experiments was 120 minutes.  The dry weight of 
TABLE  IV 
Staph.  aureus before sulfathiazole treatment  ......  Staph. aureus after sulfathiatole treatment 
Control  Sulfathiazole present  I  Control* I  Sulfathiazole present~ 
1.38 X10-s M  5.SZ  X lO-' ~  I  11.3S X IO-' M  I s.sZ X IO-' M 
c.mm. COs ..........  402  332  246  I  402  [  335  [  269 
* Sulfathiazole removed by washing. 
:~ Sulfathiazole removed by washing and added again to the system. 
daily samples (per reaction system) of Staph.  aureus was 4 mg., E.  coli 3.96 
mg., and 5 to 10 rag. of air-dried brewer's yeast.  (Table III.) 
Removal  of  Sulfathiazole  from  Sulfathiazole-Treated  Staphylococcus  aureus 
In the previous communication it was suggested that the drugs either com- 
bine with the enzyme system forming a  "drug-protein-coenzyme" complex or 
displace coenzyme forming a "drug-protein" enzyme analogue. 
The result of the experiment, given in Table IV, does not give evidence of 
displacement of cocarboxylase; the drug may possibly have formed a  hypo- 
thetical reversible  "drug-protein-cocarboxylase" complex.  A  fresh  16  hour 
culture of Staph.  aureus was washed with ~r/15 phosphate buffer of pH 7.16. 
A dense 2 cc. suspension was treated with 30 cc. of 5.52 X  10  -3 x~ sulfathiazole 
solution for 35 minutes at 37.5°C.  The suspension was then centrifuged and 
twice washed with phosphate buffer.  A  control containing no  sulfathiazole 
was given identical treatment.  The COs production was then measured in the 
Barcroft-Warburg set-up. 
DISCUSSION 
Suspensions of Streptococcus  pyogenes  exercised  weak carboxylase activity. 
The addition of 25-100 "r of cocarboxylase (Merck's) to the reaction system ac- M:.  G.  SEVAG~ M'.  SHELBURNE,  AND  S.  MUDD  813 
celerated carboxylase activity several fold.  It appears that the carboxylase of 
the suspension of this organism is impaired in some manner, or perhaps it dis- 
sociates more readily than in other cells, and thereby the cocarboxylase is lost. 
Barron and Jacobs (8)  state that in the absence of oxygen pyruvic acid is 
split by hemolytic streptococci into acetic acid and formic acid: 
CHsCOCOOH  +  H20  ~ CI-IsCOOH  +  HCOOH 
Our findings show definitely that the anaerobic metabolism of pyruvic acid in- 
volves also its decarboxylation by streptococcal  carboxylase: 
CHsCOCOOH  ~ CHsCHO +  COs 
As far as we know this fact has not been observed previously. 
The suspensions of Pneumococcus Type 1 did not exercise activity even in 
the presence of 1-100 7 of cocarboxylase.  The metabolism of pyruvic acid by 
pneumococci must therefore take place by a different mechanism.  Sevag (2) 
previously showed that hydrogen  peroxide formed from the oxidation of glucose 
and lactic acid reacts instantaneously with the pyruvic acid resulting simul- 
taneously, and produces acetic acid, carbon dioxide, and water.  In the absence 
of carboxylase in the pneumococcic cells this appears to be the principle mech- 
anism of the decarboxylation  of pyruvic acid. 
The production of COs from the anaerobic  metabolism of pyruvic acid in 
Staph.  aureus,  E.  coli,  brewer's yeast, and baker's yeast and a  carboxylase 
preparation from brewer's yeast is inhibited by sulfonamide drugs to varying 
degrees.  The results are given in Table III. 
The results clearly show that the thlazole  group is the most effective in- 
hibitor  of staphylococcal carboxylase;  similarly of the  E.  coli  carboxylase. 
Yeast carboxylase  and carboxylase  prepared from yeast are inhibited by the 
substances containing pyrimidine, pyridine, and thlazole rings to similar degree, 
except in sulfamethyldiazine  which is completely  ineffective on all the organisms 
studied. 
At 1.38 X  10  -3  ~  concentration, 2-aminopyrimidine  and  2-aminothiazole 
show practically no inhibition of Staph.  aureus and E. coli carboxylases.  An 
increase in concentration of 2-aminopyrimidine  to 5.52 X  10  --8 ~r shows no in- 
crease in inhibition.  However, an increase of 2-aminothlazole to 5.52 ×  10  --3 
concentration results in an inhibition three to five times as great, indicating a 
definite affinity between this  thlazole  ring and  the  enzyme system.  With 
yeast an increase  in molarity resulted in an increase  in inhibition by both 
substances.  (See  also footnote ** to Table III.) 
Of all the substances  tested, 2-sulfanilamido-5-ethyl-4-thlazolone  appears to 
be the most effective inhibitor on E. coli and Stapk. aureus.  Its effect on yeast, 
however, is about equal to that of sulfathiazole.  It is also interesting to note 
that a methyl group on sulfadiazine obviates its inhibitory effect nearly com- 
pletely, whereas a methyl group on sulfathiazole does not lessen the inhibitory 
effect on Staph. aureus and E. coli, and somewhat increases this effect on yeast. 814  RESPIRATION  0~'  BACTERIA  AND  YEAST 
While the inhibiting effect of 27.6 X  10  -~ M sulfanilamide on Stapk. aureus is 
negligible, it inhibits E. coli, yeast, and carboxylase, respectively, 41, 56.3, and 
62  per  cent.  This shows  that enzyme proteins in these organisms  exhibit 
different  affinities towards this substance. 
According  to Buchman, Heegard, and Bonner (9)  thiazole  pyrophosphate 
markedly inhibits the activity of cocarboxylase.  Neither thiazole, nor pyro- 
phosphate alone exercised any inhibiting effect in their experiments.  The union 
between  thiazole  pyrophosphate  and  carboxylase  protein  is  stated  to  be 
through the pyrophosphate group which is common to both the cocarboxyiase 
and the inhibitor.  In our study, we did not find the presence of pyrophosphate 
group  an essential  factor in demonstrating the inhibitory effect  of the sul- 
fonamides and the thiazole ring on the enzyme system. 
A comparison of the chemical structures of the drugs containing the pyrim- 
idine  and  thiazole  rings  with  the chemical structure of  cocarboxylase  con- 
taining both rings may help to evaluate the degree of inhibition one can expect 
them to exercise on the carboxylase system.  The results in Table III permit 
us to state that thiazole groups exercise a high degree of specific inhibition on 
the Stapk. aureus and the E. coli systems.  On the other hand, the carboxylase 
system of yeast and a carboxylase preparation from yeast are equally affected 
by  sulfonamides  containing pyrimidine,  thiazole,  and  pyridine  rings;  sul- 
famethyldiazine,  however, is completely ineffective on all the organisms studied. 
Sulfanilamide appears to possess the smallest affinity for the enzyme system. 
However,  it is  a  potential inhibitor, and this potentiality demonstrates its 
power when rings such as pyridine, pyrimidine, and thiazole are attached to 
the sulfamido group. 
It is  interesting in this connection  to refer to  the  observation made by 
Rammelkamp and Jewell  (10) on the effect of sulfadiazine  and sulfathiazole 
on the growth of Stapk. aureus.  They found that sulfathiazole added to blood 
exercised a  somewhat greater effect than sulfadiazine  against staphylococci. 
Moreover, the action of sulfathiazole becomes manifest at lower concentrations. 
When the drugs were administered orally, sulfathiazole invariably produced an 
increase  in the bactericidal action of the blood as great or greater than sul- 
fadiazine,  even though the  concentration of sulfadiazine  was  twice  that of 
sulfathiazole.  Similarly the results obtained by Straus, Dingle,  and Finland 
(11) show that sulfathiazole is about 4 times as effective as sulfadiazine, 8 times 
as effective as sulfanilamide,  and 5-6 times as sulfapyridine on the growth of 
Staph. aureus.  Their comparative studies (11) on the inhibition of the growth 
of E. coli with these drugs yielded similar results.  In this case, sulfathiazole 
was 5 times as effective as suffapyridine, twice as effective as sulfadiazine and 
40-50 times as sulfanilamide. 
The results given by us in Table III seem to corroborate satisfactorily the 
findings of the above  cited investigators.  The relative effectiveness of these = ~\l/g 
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drugs  on  the inhibition  of growth  and  the  inhibition  of the metabolism of 
pyruvic acid seems to point to a possible direct relationship, emphasizing the 
importance  of pyruvic  acid  metabolism  during  the  multiplication  of  these 
organisms.  On the other hand the failure to find carboxylase in pneumococci 
suggests that sulfathiazole may inhibit  some other enzyme than  carboxylase 
in these microorganisms. 
If the sulfonamide drugs exercise  their inhibitory effect on enzymes in part 
by virtue of the similarity of their  structure  to  the  coenzyme molecule,  as 
the results presented in this study appear to indicate, then another  group  of 
biologically active  substances,  such  as  vitamins  and  vitamin  derivatives, 
structurally related to both the drugs and the coenzymes, might be expected 
to  modify the  inhibitory action of the drugs.  The present study  is  being 
followed by an investigation of this problem. 
Since cozymases, like carboxylases, are universally present in the respiratory 
enzyme  system,  the  possible relation  of  the  action  of sulfonamides  to  the 
structural similarity existing between them and the cozymases must likewise 
be investigated.  The result of such an investigation will no doubt be signifi- 
cant from the point of view of the theory concerning  the mechanism of anti- 
bacterial drug action. 
The authors wish to express their thanks to Mr. J. Smolens for the nitrogen 
determinations  and  to Mr.  M.  Ibsen for the  technical  assistance  rendered. 
Thanks are due also to Merck and  Company, Dr. M. L. Moore of Sharp  & 
Dohme, and Dr. R. O. Roblin, Jr., of the American Cyanamid Company for 
some of the substances used in this investigation. 
SUMMARY 
The inhibiting effects of sulfonamide drugs and their derivatives on the anae- 
robic decarboxylation of pyruvic acid by Staphylococcus aureus, Escherichia coli, 
baker's and brewer's yeast, and a carboxylase preparation from brewer's yeast 
have been investigated.  These drugs  are:  sulfanilamide, sulfapyridine, sup 
fadlazine,  sulfamethyldiazine, sulfathiazole, sulfamethylthlazole, sulfanilamido- 
5-ethyl-4-thiazolone,  2-aminopyrimidine, 2-aminothiazole,  and 2-aminopyridine. 
The sulfathiazole ring appears to exercise decidedly greater specific inhibiting 
effect on the carboxylases of Staph. aureus and E. coli.  The inhibiting effect 
on  yeast  carboxylase  is  non-differentiable  among  all  the  substances  tried, 
except sulfamethyldiazine which is completely ineffective on the carboxylases 
of the organisms studied. 
The specific inhibitory effect of sulfathlazole on the carboxylases of Staph. 
aureus and E. coli in comparison to sulfanilamide,  sulfapyridine, and sulfadi- 
azine  is  in harmony with in  vivo  and  in vitro  experimental  results of other 
investigators. M.  G.  SEVAG, M.  SHELBURNE, AND S.  MUDD  817 
The  results  of the present  investigation  appear  to support  the hypothesis 
(1) that sulfonamides exert their bacteriostatic action through chemical affinity 
for the carrier proteins of certain respiratory enzymes of the bacterial cell, and 
that this affinity may in part be related  to structural similarity between com- 
ponents of the drugs and the corresponding respiratory coenzymes. 
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